Back to Search Start Over

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.

Authors :
Sie, Aisha
Zelst-Stams, Wendy
Spruijt, Liesbeth
Mensenkamp, Arjen
Ligtenberg, Marjolijn
Brunner, Han
Prins, Judith
Hoogerbrugge, Nicoline
Source :
Familial Cancer; Jun2014, Vol. 13 Issue 2, p143-151, 9p
Publication Year :
2014

Abstract

Currently, most breast cancer (BC) patients receive face-to-face genetic counseling (DNA-intake) prior to BRCA-mutation testing, with generic information regarding hereditary BC and BRCA-mutation testing. This prospective study evaluated a novel format: replacing the intake consultation with telephone, written and digital information sent home, and face-to-face contact following BRCA-mutation testing (DNA-direct). From August 2011 to February 2012, 161 of 233 eligible BC patients referred to our Human Genetics department chose between DNA-direct (intervention) or DNA-intake (control). Exclusion criteria were psychological problems (n = 33), difficulty with Dutch text (n = 5), known BRCA-family (n = 3), non- BRCA-referral (n = 1). 30 declined genetic counseling or study participation. Participants received questionnaires including satisfaction and psychological distress. 59 % chose DNA-direct ( p = 0.03), of whom 90 % were satisfied and would choose DNA-direct again (including 6/8 BRCA-mutation carriers); although 27 % hesitated to recommend DNA-direct to other patients. General distress (GHQ-12, p = 0.001) and heredity-specific distress (IES, p = 0.02) scored lower in DNA-direct than DNA-intake, both at baseline and follow-up 2 weeks after BRCA-result disclosure; all scores remained below clinical relevance. DNA-direct participants reported higher website use (53 vs. 32 %, p = 0.01), more referrer information about personal consequences (41 vs. 20 %, p = 0.004) and lower decisional conflict (median 20 [0-88] vs. 25 [0-50], p = 0.01). Processing time in DNA-direct was reduced by 1 month. Mutation detection rate was 8 % in both groups. All BRCA-mutation carriers fulfilled current testing criteria. In conclusion, more BC patients preferred DNA-direct over intake consultation prior to BRCA-mutation testing, the majority being strongly to moderately satisfied with the procedure followed, without increased distress. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13899600
Volume :
13
Issue :
2
Database :
Complementary Index
Journal :
Familial Cancer
Publication Type :
Academic Journal
Accession number :
96152180
Full Text :
https://doi.org/10.1007/s10689-013-9686-z